Gene-Editing Transfection Chemicals Global Market Report 2025
상품코드:1810899
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
유전자 편집용 형질전환 화학물질 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.8%로 14억 5,000만 달러에 달할 전망입니다. 예측 기간 동안 예상되는 성장은 임상 치료에서 유전자 편집의 적용 확대, 생명공학 및 제약 부문의 투자 증가, 비바이러스 전달 방법에 대한 수요 증가, 희귀 및 유전성 질환의 발생률 증가, 개인 맞춤형 의료에 대한 전 세계적인 관심, 재생 치료의 발전으로 인해 발생할 것으로 예측됩니다. 이 시기를 형성할 것으로 예상되는 주요 동향으로는 나노입자 및 지질 기반 전달 시스템으로의 전환, 자동화 및 고성능 기술 채택, 마이크로플루이딕스 및 단일 세포 전달 기술의 부상, 나노기술의 통합, 코어 쉘 실리카 나노입자 플랫폼의 개발 등이 있습니다.
유전자 치료 연구의 가속화는 향후 몇 년 동안 유전자 치료 시장의 성장을 견인할 것으로 예측됩니다. 유전자 치료는 개인의 세포 내 결함 유전자를 직접 변형 또는 수정하여 질병을 치료하거나 예방하는 기술입니다. 유전자 치료의 발전은 CRISPR과 같은 유전자 편집 기술의 비약적인 발전으로 가속화되고 있으며, 과학자들은 유전성 질환을 일으키는 결함 유전자를 정확하게 겨냥하여 수정할 수 있습니다. 유전자교정용 트랜스펙션 케미컬은 CRISPR-Cas9 성분, mRNA, 플라스미드 DNA 등의 유전물질을 인간 세포 내로 효율적으로 전달할 수 있도록 함으로써 유전자치료제 연구개발에 중요한 역할을 하고 있습니다. 예를 들어, 2024년 8월 스위스에 본사를 둔 보험사 PartnerRe는 2023년 말까지 FDA가 7개의 유전자 치료제를 승인했고, 2024년 상반기에 7개를 추가로 승인해 새로운 기록을 세울 것으로 예상한다고 보고했습니다. 현재 500개 이상의 유전자 치료제가 개발 중이며, FDA는 2025년까지 10-20개의 유전자 및 세포 치료제가 추가로 승인될 것으로 예상하고 있습니다. 그 결과, 유전자 치료의 급속한 발전은 유전자 편집용 트랜스펙션 케미컬 시장의 확대에 박차를 가하고 있습니다.
유전자 편집용 전사체 시장의 주요 기업들은 유전자 치료 및 mRNA 전달 과정을 간소화하기 위해 지질 나노입자(LNP) 스타터 키트와 같은 혁신적인 솔루션을 출시하는 데 주력하고 있습니다. 지질 나노입자(LNP) 스타터 키트는 LNP 기반 전달 시스템 개발 및 검사를 지원하기 위해 설계된 사전 최적화된 지질 성분과 프로토콜이 포함된 즉시 사용 가능한 제제 또는 툴킷입니다. 예를 들어, 스위스 제약회사 코덴파마는 2024년 2월, 백신 및 유전자 치료를 포함한 mRNA 기반 치료제의 배합 및 최적화를 위한 연구 개발을 지원하기 위한 지질 나노입자(LNP) 스타터 키트를 발표했습니다. 이 키트에는 이온화 가능 지질, 헬퍼 지질, 스테롤, PEG화 지질 등 4가지 필수 지질이 포함되어 있으며, 배치 간 일관성을 보장하고 개발 중 귀중한 페이로드가 손실될 위험을 최소화하기 위해 상업적 규모의 고순도 재료를 사용하고 있습니다. 코덴파마는 신뢰할 수 있고 확장 가능한 지질 플랫폼을 제공함으로써 고부가가치 유전자 페이로드를 보호하면서 유전자 편집 및 mRNA 치료제 개발을 가속화하는 것을 목표로 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계 성장 분석과 전략 분석 프레임워크
세계의 유전자 편집용 형질전환 화학제품 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 유전자 편집용 형질전환 화학제품 시장 : 성장률 분석
세계의 유전자 편집용 형질전환 화학제품 시장 실적 : 규모와 성장, 2019-2024년
세계의 유전자 편집용 형질전환 화학제품 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 유전자 편집용 형질전환 화학제품 : 전체 시장(TAM)
제6장 시장 세분화
세계의 유전자 편집용 형질전환 화학제품 시장 : 화학제품 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
지질 기반
폴리머 기반
펩티드 기반
기타 화학제품 유형
세계의 유전자 편집용 형질전환 화학제품 시장 : 감염 메커니즘별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
비바이러스성
바이러스성
세계의 유전자 편집용 형질전환 화학제품 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
생물의학 연구
Drug Discovery
질환 모델
농업 생명공학
백신 개발
기타
세계의 유전자 편집용 형질전환 화학제품 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
학술연구기관
바이오테크놀러지 기업
제약회사
기타
세계의 유전자 편집용 형질전환 화학제품 시장 : 지질 기반별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
양이온성 지질
중성 지질
이온화 지질
세계의 유전자 편집용 형질전환 화학제품 시장 : 폴리머 기반별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
Polyethyleneimine (PEI)
Poly(L-lysine) (PLL)
Dendrimers
세계의 유전자 편집용 형질전환 화학제품 시장 : 펩티드 기반별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세포 침투 펩티드(CPP)
양친매성 펩티드
표적 펩티드
세계의 유전자 편집용 형질전환 화학제품 시장 : 기타별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
무기 나노입자
하이브리드 나노입자
제7장 지역별/국가별 분석
세계의 유전자 편집용 형질전환 화학제품 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 유전자 편집용 형질전환 화학제품 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
유전자 편집용 형질전환 화학제품 시장 : 경쟁 구도
유전자 편집용 형질전환 화학제품 시장 : 기업 개요
Thermo Fisher Scientific Inc.
Merck KGaA
Agilent Technologies Inc.
Lonza Group AG
Sartorius AG
제31장 기타 주요 기업 및 혁신 기업
Bio-Rad Laboratories Inc.
Takara Bio Inc.
GenScript BIoTech Corporation
Integrated DNA Technologies Inc.
Promega Corporation
Eurogentec S.A.
Horizon Discovery Group plc
OriGene Technologies Inc.
Enzo Life Sciences Inc.
Apollo Scientific Ltd.
Mirus Bio LLC
OZ Biosciences SAS
Genlantis Inc.
Polyplus-Transfection SA
Altogen Biosystems LLC
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 전략
유전자 편집용 형질전환 화학제품 시장, 2029년 : 새로운 기회를 제공하는 국가
유전자 편집용 형질전환 화학제품 시장, 2029년 : 새로운 기회를 제공하는 부문
유전자 편집용 형질전환 화학제품 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Gene-editing transfection chemicals are specially designed substances that enable the efficient transfer of gene-editing tools like CRISPR-Cas9 complexes, plasmid DNA, or RNA molecules into living cells by helping them cross the cell membrane intact. These agents are vital for achieving high transfection efficiency and successful genome editing because they safeguard the genetic material and support its uptake, expression, and function within the target cells.
The primary types of gene-editing transfection chemicals include lipid-based, polymer-based, peptide-based, and others. Lipid-based transfection agents consist of lipid molecules that assist in delivering gene-editing tools such as CRISPR-Cas9 into cells. These chemicals use various delivery strategies, including both viral and non-viral methods, and have applications across biomedical research, drug discovery, disease modeling, agricultural biotechnology, vaccine development, and more. Their main users are academic and research institutions, biotechnology firms, pharmaceutical companies, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The gene-editing transfection chemicals market research report is one of a series of new reports from The Business Research Company that provides gene-editing transfection chemicals market statistics, including gene-editing transfection chemicals industry global market size, regional shares, competitors with a gene-editing transfection chemicals market share, detailed gene-editing transfection chemicals market segments, market trends and opportunities, and any further data you may need to thrive in the gene-editing transfection chemicals industry. This gene-editing transfection chemicals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The gene-editing transfection chemicals market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The expansion during the historic period was driven by the early implementation of CRISPR-Cas9 technology, increased emphasis on cancer and genetic disorder studies, initial demand from academic and research organizations, the accessibility of fundamental chemical transfection reagents, and the swift advancement of cell biology and molecular diagnostics.
The gene-editing transfection chemicals market size is expected to see strong growth in the next few years. It will grow to $1.45 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The projected growth during the forecast period is driven by the expanding application of gene editing in clinical therapies, increased investments from biotech and pharmaceutical sectors, rising demand for non-viral delivery methods, growing incidence of rare and inherited diseases, worldwide focus on personalized medicine, and the advancement of regenerative treatments. Key trends expected to shape this period include a move toward nanoparticle and lipid-based delivery systems, the adoption of automation and high-throughput technologies, the rise of microfluidic and single-cell delivery techniques, integration of nanotechnology, and the development of core-shell silica nanoparticle platforms.
The accelerated research in gene therapy is anticipated to drive the growth of the gene-editing transfection chemicals market in the coming years. Gene therapy is a technique aimed at treating or preventing diseases by directly modifying or correcting defective genes within an individual's cells. Progress in gene therapy is speeding up due to breakthroughs in gene-editing technologies like CRISPR, which allow scientists to accurately target and alter faulty genes responsible for genetic disorders. Gene-editing transfection chemicals play a crucial role in gene therapy research and development by enabling the efficient delivery of genetic materials such as CRISPR-Cas9 components, mRNA, and plasmid DNA into human cells. For example, in August 2024, PartnerRe, a Switzerland-based insurance company, reported that by the end of 2023, the FDA had approved 7 gene therapies, with 2024 expected to set a new record by approving seven more within the first half of the year. Currently, over 500 gene therapies are in development, and the FDA is projected to approve an additional 10 to 20 gene and cell therapies by 2025. Consequently, the rapid advancements in gene therapy are fueling the expansion of the gene-editing transfection chemicals market.
Leading companies in the gene-editing transfection chemicals market are concentrating on launching innovative solutions, such as lipid nanoparticle (LNP) starter kits, to simplify gene therapy and mRNA delivery processes. Lipid nanoparticle (LNP) starter kits are ready-to-use formulations or toolkits that include pre-optimized lipid components and protocols designed to aid in the development and testing of LNP-based delivery systems. For instance, in February 2024, CordenPharma, a Switzerland-based pharmaceutical firm, introduced Lipid NanoParticle (LNP) Starter Kits intended to assist researchers and developers in formulating and optimizing mRNA-based therapeutics, including vaccines and gene therapies. These kits feature four essential lipids - ionizable lipids, helper lipids, sterols, and PEGylated lipids - sourced from commercial-scale, high-purity materials to ensure consistency between batches and minimize the risk of losing valuable payloads during development. By offering a dependable and scalable lipid platform, CordenPharma aims to speed up the development of gene editing and mRNA therapeutics while protecting high-value genetic payloads.
In August 2024, Merck KGaA, a Germany-based science and technology company, acquired Mirus Bio LLC for $600 million. Through this acquisition, Merck seeks to enhance its goal of providing fully integrated and comprehensive solutions for all stages of viral vector manufacturing, supporting the development and commercialization of cell and gene therapies from preclinical research through to commercial production. Mirus Bio LLC, based in the US, produces transfection reagents used in gene editing and other cell and gene therapy applications.
Major players in the gene-editing transfection chemicals market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Bio-Rad Laboratories Inc., Takara Bio Inc., GenScript Biotech Corporation, Integrated DNA Technologies Inc., Promega Corporation, Eurogentec S.A., Horizon Discovery Group plc, OriGene Technologies Inc., Enzo Life Sciences Inc., Apollo Scientific Ltd., Mirus Bio LLC, OZ Biosciences SAS, Genlantis Inc., Polyplus-Transfection SA, Altogen Biosystems LLC, Canvax Biotech S.L., EZ Biosystems LLC, and SignaGen Laboratories.
North America was the largest region in the gene-editing transfection chemicals market in 2024. The regions covered in gene-editing transfection chemicals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the gene-editing transfection chemicals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gene-editing transfection chemicals market consists of sales of products, including lipid-based transfection reagents, polymer-based transfection reagents, electroporation buffers and kits, nanoparticle-based delivery systems, and cell-specific transfection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Gene-Editing Transfection Chemicals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on gene-editing transfection chemicals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for gene-editing transfection chemicals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene-editing transfection chemicals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Chemical Type: Lipid-Based; Polymer-Based; Peptide-Based; Other Chemical Types
2) By Delivery Mechanism: Non-Viral; Viral
3) By Application: Biomedical Research; Drug Discovery; Disease Modeling; Agricultural Biotechnology; Vaccine Development; Other Applications
4) By End-User: Academic And Research Institutes; Biotechnology Companies; Pharmaceutical Companies; Other End-Users
Subsegments:
1) By Lipid-Based: Cationic Lipids; Neutral Lipids; Ionizable Lipids
2) By Polymer-Based: Polyethyleneimine (PEI); Poly(L-Lysine) (PLL); Dendrimers
3) By Peptide-Based: Cell-Penetrating Peptides (CPPs); Amphipathic Peptides; Targeting Peptides
4) By Other Chemical Types: Inorganic Nanoparticles; Hybrid Nanoparticles
Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.; Lonza Group AG; Sartorius AG; Bio-Rad Laboratories Inc.; Takara Bio Inc.; GenScript Biotech Corporation; Integrated DNA Technologies Inc.; Promega Corporation; Eurogentec S.A.; Horizon Discovery Group plc; OriGene Technologies Inc.; Enzo Life Sciences Inc.; Apollo Scientific Ltd.; Mirus Bio LLC; OZ Biosciences SAS; Genlantis Inc.; Polyplus-Transfection SA; Altogen Biosystems LLC; Canvax Biotech S.L.; EZ Biosystems LLC; SignaGen Laboratories.
3. Gene-Editing Transfection Chemicals Market Trends And Strategies
4. Gene-Editing Transfection Chemicals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Gene-Editing Transfection Chemicals Growth Analysis And Strategic Analysis Framework
5.1. Global Gene-Editing Transfection Chemicals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gene-Editing Transfection Chemicals Market Growth Rate Analysis
5.4. Global Gene-Editing Transfection Chemicals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gene-Editing Transfection Chemicals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gene-Editing Transfection Chemicals Total Addressable Market (TAM)
6.1. Global Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lipid-Based
Polymer-Based
Peptide-Based
Other Chemical Types
6.2. Global Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Viral
Viral
6.3. Global Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biomedical Research
Drug Discovery
Disease Modeling
Agricultural Biotechnology
Vaccine Development
Other Applications
6.4. Global Gene-Editing Transfection Chemicals Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Academic And Research Institutes
Biotechnology Companies
Pharmaceutical Companies
Other End-Users
6.5. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Lipid-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cationic Lipids
Neutral Lipids
Ionizable Lipids
6.6. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Polymer-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polyethyleneimine (PEI)
Poly(L-lysine) (PLL)
Dendrimers
6.7. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Peptide-Based, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cell-Penetrating Peptides (CPPs)
Amphipathic Peptides
Targeting Peptides
6.8. Global Gene-Editing Transfection Chemicals Market, Sub-Segmentation Of Other Chemical Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inorganic Nanoparticles
Hybrid Nanoparticles
7. Gene-Editing Transfection Chemicals Market Regional And Country Analysis
7.1. Global Gene-Editing Transfection Chemicals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gene-Editing Transfection Chemicals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Gene-Editing Transfection Chemicals Market
9.1. China Gene-Editing Transfection Chemicals Market Overview
9.2. China Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Gene-Editing Transfection Chemicals Market
10.1. India Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Gene-Editing Transfection Chemicals Market
11.1. Japan Gene-Editing Transfection Chemicals Market Overview
11.2. Japan Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Gene-Editing Transfection Chemicals Market
12.1. Australia Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Gene-Editing Transfection Chemicals Market
13.1. Indonesia Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Gene-Editing Transfection Chemicals Market
14.1. South Korea Gene-Editing Transfection Chemicals Market Overview
14.2. South Korea Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Gene-Editing Transfection Chemicals Market
15.1. Western Europe Gene-Editing Transfection Chemicals Market Overview
15.2. Western Europe Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Gene-Editing Transfection Chemicals Market
16.1. UK Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Gene-Editing Transfection Chemicals Market
21.1. Eastern Europe Gene-Editing Transfection Chemicals Market Overview
21.2. Eastern Europe Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Gene-Editing Transfection Chemicals Market
22.1. Russia Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Gene-Editing Transfection Chemicals Market
23.1. North America Gene-Editing Transfection Chemicals Market Overview
23.2. North America Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Gene-Editing Transfection Chemicals Market
24.1. USA Gene-Editing Transfection Chemicals Market Overview
24.2. USA Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Gene-Editing Transfection Chemicals Market
26.1. South America Gene-Editing Transfection Chemicals Market Overview
26.2. South America Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Gene-Editing Transfection Chemicals Market
27.1. Brazil Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Gene-Editing Transfection Chemicals Market
28.1. Middle East Gene-Editing Transfection Chemicals Market Overview
28.2. Middle East Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Gene-Editing Transfection Chemicals Market
29.1. Africa Gene-Editing Transfection Chemicals Market Overview
29.2. Africa Gene-Editing Transfection Chemicals Market, Segmentation By Chemical Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gene-Editing Transfection Chemicals Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gene-Editing Transfection Chemicals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Gene-Editing Transfection Chemicals Market Competitive Landscape And Company Profiles
